Download MS Office

Word when and where you need it

Word works across your devices. Install the Word mobile app to stay productive on the go.

A tablet showing a Word document in Read Mode.

Can you read me? Loud and clear.

Easy reading

In Read Mode, text reflows in columns automatically for easier on-screen reading. And fewer menus–only tools that add value to your reading–keep you focused on your content.

Easy writing

The familiar Word program lets you create, edit, and share work quickly and easily. Most people can open and work with a document in Word. It’s the most popular word processing program in the world.

Easy everywhere

With OneDrive, you’ll have 15 GB of storage in the cloud, So when you install Office apps on your mobile devices, you can access the latest version of your files anytime, anywhere.

http://products.office.com/en-IN/business/compare-office-365-for-business-plans

A PC monitor showing the sharing options in Microsoft Word.

It’s not just words. It’s a conversation.

Get together

Sharing is simplified. Your files are saved online on OneDrive or SharePoint by default. Just send everyone a single link to the same file, along with viewing and editing permissions. You’ll all have the latest version of the file.

Work together

You and your team can converse, collaborate and co-author your documents in real-time with Word Online.

Stay on track

Track changes, and add or reply to comments right next to the text you’re discussing. Everyone can follow the conversation and stay on top of changes to the text, layout and formatting.

A laptop showing two different live layouts side by side of a single Word document.

Now, that’s nicely done.

It’s polished

Experiment with Live Layouts on your desktop and tablet. Drag a photo, video, or shape to where you want them and the text reflows right before your eyes. Release the mouse button and your object and surrounding text stay right where you’ve put them.

It’s professional

Give your documents a professional look—align charts, photos, videos, and diagrams with your text. Handy alignment guides pop into place when you need them and disappear when you’re done.

It works with PDFs

Here’s a time-saver you'll really love: Open a PDF in Word on your desktop, and you can edit content, such as paragraphs, lists and tables, as if you created it in Word.

Comments

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition. In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates. So, why is this approval so important? First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com . Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead. CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday. It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly? The answer isn't clear yet. We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct. But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side

DBTECH

Search This Blog